Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Singapore, Singapore, July 07, 2023 (GLOBE NEWSWIRE) -- ATPBot, an automated trading robot that helps users automate their trading announced a new set of tools to help its users ease out the process...
-
ANN ARBOR, Mich., July 07, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the presentation of a key abstract at the 2023 ASPC Congress on CVD Prevention taking place on July 21-23,...
-
Company announcement 27/2023 Major shareholder announcement Kolding, Denmark, 7 July 2023 - Green Hydrogen Systems A/S (the “Company”) announces receipt of the following notifications pursuant to...
-
GARDEN GROVE, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- IGadgets announces a collaboration with Lumaflex, the creator of the world's first portable, waterproof red light therapy device. IGadgets has...
-
NEWARK, Del, July 03, 2023 (GLOBE NEWSWIRE) -- As per Future Market Insights (FMI), the global digital textile printer market is estimated to reach US$ 2,212.9 million in 2023. Over the forecast...
-
IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
-
London, June 30, 2023 (GLOBE NEWSWIRE) -- With a joint commitment to expanding opportunities for professional women’s and men’s tennis players on and off the court, the Professional Tennis Players...
-
Preclinical data highlights ciforadenant’s mechanism of action and synergy with immune checkpoint inhibitors Enrollment continues in Phase 1b/2 clinical trial evaluating ciforadenant as a potential...
-
Alvotech (NASDAQ: ALVO) tilkynnti í dag að Matvæla- og lyfjaeftirlit Bandaríkjanna (FDA) hefði sent svar við annarri umsókn félagsins um markaðsleyfi fyrir AVT02, sem jafnframt inniheldur gögn sem...
-
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug...